Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Cell Mol Med. 2010 Jul;14(7):1904-16. doi: 10.1111/j.1582-4934.2010.01071.x. Epub 2010 Apr 19.
Morphometric evidence derived from studies of mast cells, pancreatic acinar cells and other cell types supports a model in which the post-Golgi processes that generate mature secretory granules can be resolved into three steps: (1) fusion of small, Golgi-derived progranules to produce immature secretory granules which have a highly constrained volume; (2) transformation of such immature granules into mature secretory granules, a process often associated with a reduction in the maturing granule's volume, as well as changes in the appearance of its content and (3) fusion of secretory granules of the smallest size, termed 'unit granules', forming granules whose volumes are multiples of the unit granule's volume. Mutations which perturb this process can cause significant pathology. For example, Chediak-Higashi syndrome / lysosomal trafficking regulator (CHS)/(Lyst) mutations result in giant secretory granules in a number of cell types in human beings with the Chediak-Higashi syndrome and in 'beige' (Lyst(bg)/Lyst(bg)) mice. Analysis of the secretory granules of mast cells and pancreatic acinar cells in Lyst-deficient beige mice suggests that beige mouse secretory granules retain the ability to fuse randomly with other secretory granules no matter what the size of the fusion partners. By contrast, in normal mice, the pattern of granule-granule fusion occurs exclusively by the addition of unit granules, either to each other or to larger granules. The normal pattern of fusion is termed unit addition and the fusion evident in cells with CHS/Lyst mutations is called random addition. The proposed model of secretory granule formation has several implications. For example, in neurosecretory cells, the secretion of small amounts of cargo in granules constrained to a very narrow size increases the precision of the information conveyed by secretion. By contrast, in pancreatic acinar cells and mast cells, large granules composed of multiple unit granules permit the cells to store large amounts of material without requiring the amount of membrane necessary to package the same amount of cargo into small granules. In addition, the formation of mature secretory granules that are multimers of unit granules provides a mechanism for mixing in large granules the contents of unit granules which differ in their content of cargo.
形态计量学证据来源于对肥大细胞、胰腺腺泡细胞和其他细胞类型的研究,支持这样一种模型,即生成成熟分泌颗粒的高尔基体后过程可以分为三个步骤:(1)小的、来源于高尔基体的前颗粒融合,产生具有高度受限体积的不成熟分泌颗粒;(2)这种不成熟颗粒转化为成熟分泌颗粒的过程,通常与成熟颗粒体积的减少以及其内容物外观的变化相关联;(3)最小尺寸的分泌颗粒融合,称为“单位颗粒”,形成体积是单位颗粒倍数的颗粒。扰乱这一过程的突变可导致显著的病理。例如,Chediak-Higashi 综合征/溶酶体运输调节剂(CHS)/(Lyst)突变导致人类 Chediak-Higashi 综合征和“beige”(Lyst(bg)/Lyst(bg))小鼠的许多细胞类型中的巨大分泌颗粒。对 Lyst 缺陷型 beige 小鼠的肥大细胞和胰腺腺泡细胞的分泌颗粒进行分析表明,beige 小鼠的分泌颗粒无论融合伙伴的大小如何,仍然保留着随机与其他分泌颗粒融合的能力。相比之下,在正常小鼠中,颗粒-颗粒融合的模式仅通过添加单位颗粒来发生,无论是彼此之间还是与较大的颗粒之间。正常的融合模式称为单位添加,在具有 CHS/Lyst 突变的细胞中可见的融合称为随机添加。分泌颗粒形成的拟议模型有几个含义。例如,在神经分泌细胞中,受限制在非常狭窄尺寸的颗粒中少量货物的分泌增加了通过分泌传递的信息的精度。相比之下,在胰腺腺泡细胞和肥大细胞中,由多个单位颗粒组成的大颗粒允许细胞储存大量物质,而无需包装相同数量的货物到小颗粒所需的膜量。此外,成熟分泌颗粒是单位颗粒的多聚体的形成提供了一种机制,用于在大颗粒中混合在货物含量上不同的单位颗粒的内容物。